Concentration/Meditation Limits Inflammation

NCT01835457 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: Lipopolysaccharide
BEHAVIORAL: Concentration/meditation

Sponsor

Radboud University Medical Center